KLRS

Kalaris Therapeutics

84 hedge funds and large institutions have $110M invested in Kalaris Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$129K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.8M
2 +$2.94M
3 +$970K
4
BlackRock
BlackRock
New York
+$966K
5
State Street
State Street
Massachusetts
+$566K

Top Sellers

1 -$9.72M
2 -$2.92M
3 -$2.46M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$922K
5
Citadel Advisors
Citadel Advisors
Florida
-$736K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$28M
2
$10.7M
3
$9.67M
4
$9.06M
5
$7.99M
6
$7.38M
7
$4.46M
8
$4.24M
9
$3.21M
10
$3.04M
11
$3.03M
12
$2.81M
13
$2.15M
14
$1.27M
15
$1.18M
16
$1.09M
17
$923K
18
$892K
19
$851K
20
$694K
21
$551K
22
$364K
23
$356K
24
$321K
25
$309K